3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Myelodysplastic Syndromes
3
Small Cell Lung Carcinoma
2
Rectal Neoplasms
2
Prostatic Neoplasms
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Lung Neoplasms
2
Vulvar Neoplasms
1
Vulvar Diseases
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Stomach Neoplasms
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Lymphoma, Primary Effusion
1
Lymphoma, B-Cell
1
Lymphoma, AIDS-Related
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Hematologic Diseases
1
Gastrointestinal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Small Cell
1
Carcinoma in Situ
1
Interventions
Dexamethasone
4
ruxolitinib
2
pomalidomide
2
daratumumab
2
Tacrolimus
2
Mycophenolic Acid
2
Lenalidomide
2
Cyclophosphamide
2
Bortezomib
2
sonidegib
1
ricolinostat
1
ponatinib
1
nirogacestat
1
fludarabine phosphate
1
fludarabine
1
dacetuzumab
1
Vorinostat
1
Stem Cell Transplantation
1
Remifentanil
1
Quality of Life
1
Methotrexate
1
Mesna
1
Melphalan
1
KW-2478
1
Hsp90 inhibitor KU757
1
Filgrastim
1
Electrocardiography
1
Cyclosporine
1
Clinical Laboratory Techniques
1
CPI-0610
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Hematologic Diseases
×
Electrocardiography
×
Clear all
NCT07387354
2026-03-16
MDS
Thomas Jefferson University
Phase 1/2
Not yet recruiting
25 enrolled